Stay updated on Obinutuzumab in ISN/RPS Class III/IV Lupus Nephritis Clinical Trial

Sign up to get notified when there's something new on the Obinutuzumab in ISN/RPS Class III/IV Lupus Nephritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Obinutuzumab in ISN/RPS Class III/IV Lupus Nephritis Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A sitewide NIH banner announces updates related to the transition from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    0.4%
    Check dated 2026-10-26T15:45:35.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A new study-record version submitted on 2026-10-15 was added to the history, listing Study Status among the updated sections.
    Difference
    0.3%
    Check dated 2026-10-19T15:48:36.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-12T15:45:47.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the study history. The previous revision entry v3.6.6 was removed.
    Difference
    0.1%
    Check dated 2026-09-21T20:40:07.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.6) was added to the record history and the prior entry (v3.6.5) was removed, updating the version trail of the study record.
    Difference
    0.1%
    Check dated 2026-08-31T17:23:22.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    The Revision tag was updated from v3.6.4 to v3.6.5, signaling a new version of the study record history.
    Difference
    0.1%
    Check dated 2026-08-10T12:49:45.000Z thumbnail image

Stay in the know with updates to Obinutuzumab in ISN/RPS Class III/IV Lupus Nephritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Obinutuzumab in ISN/RPS Class III/IV Lupus Nephritis Clinical Trial page.